|
|
News Breaks | | | | July 2, 2012 | | 07:31 EDT |  | GB | Greatbatch proposes consolidation of orthopaedics manuafcturing sites
Greatbatch Medical, a subsidiary of Greatbatch, announced a proposal to consolidate its orthopaedics manufacturing operations. The move is designed to enhance operating efficiencies and drive global growth opportunities. Under the proposal, most major functions currently performed at the company’s sites in Orvin and Corgemont, Switzerland would transfer into existing Greatbatch Medical facilities in Fort Wayne, Indiana and Tijuana, Mexico by the close of 2013. There are currently 196 persons employed in the Orvin and Corgemont facilities, of which up to 90% could be affected by the current plan. In accordance with Swiss regulations, employees have a consultation period to provide individual and collective input on the proposed plan prior to any final decision being made. The intended close of the consultation period is July 20, 2012. The company remains committed to the global and European orthopaedics markets, with the proposed structure being even more capable of meeting customer design and technical support needs. A limited number of sales, administrative and technical roles would likely remain in Switzerland, aligned with Greatbatch Medical’s regional operating model. | |
|
News For GB From The Last 14 Days Check below for free stories on GB the last two weeks. |
|
|
| June 5, 2013 | | 17:13 EDT | | GB | Greatbatch CEO sees 5% organic growth
"We’ve spent the past eight years successfully integrating and consolidating our organization. With that mission accomplished, we can set our sights squarely on our growth target to achieve 5% organic growth or better,” said Greatbatch president & CEO Thomas J. Hook. “As we shared with investors earlier this year, the company is progressing from strictly a developer of components and sub-assemblies to an organization capable of developing complete medical devices for OEM customers. Our realignment into a more unified Greatbatch will allow us to reinvest in both our core business as well as emerging platforms in pursuit of substantial growth.” | | | 17:10 EDT | | GB | Greatbatch names George Cintra Chief Technology Officer
George Cintra was formerly vice president, Research Development and Engineering, Electrochem Solutions. | | | 17:09 EDT |  | GB | Greatbatch raises FY13 adjusted EPS view to $2.00-$2.05 from $1.90-$2.00
 Subscribe for More Information | | | 17:07 EDT | | GB | Greatbatch announces reorganization, includes workforce reduction
Subscribe for More Information | |
|
|
|
|
|
|
